List of Tables 5
List of Figures 5
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Redx Pharma Acquires ROCK Inhibitor AMA0825 from Amakem 11
Partnerships 12
Horizon Discovery Enters into Research Agreement with Redx Pharma 12
Astrazeneca Enters into Research Agreement with Redx Pharma 13
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 14
Licensing Agreements 15
Deinove Enters into Option and Licensing Agreement with Redx Pharma 15
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 16
Dotmatics Enters Into Licensing Agreement With Redx Pharma 17
Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 18
Equity Offering 19
Redx Pharma to Raise USD15 Million in Private Placement of Shares 19
Redx Pharma to Raise USD3.6 Million in Rights Offering of Shares 21
Redx Pharma Raises USD14.2 Million in Private Placement of Shares 22
Redx Pharma Raises USD22.7 Million in IPO 23
Asset Transactions 24
Loxo Oncology Acquires BTK Inhibitor Program from Redx Pharma 24
Redx Pharma Plc - Key Competitors 25
Redx Pharma Plc - Key Employees 26
Redx Pharma Plc - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
May 30, 2018: Redx Pharma: Interim results for the six months ended 31 March 2018 28
Dec 20, 2017: Redx Pharma: Final Results for the Year Ended 30 September 2017 31
May 17, 2017: Redx Pharma: Interim Results for the six months ended 31 March 2017 33
Mar 21, 2017: Redx Pharma Announces Final results for the year ended 30 September 2016 34
Corporate Communications 35
Jun 04, 2018: REDX PHARMA: Directorate Update 35
Jun 04, 2018: Redx Pharma Appoints Lisa Anson As Chief Executive Officer 36
Aug 14, 2017: Redx announces the resignation of Non-Executive Director David Lawrence 37
Apr 20, 2017: Redx Pharma: Appointment of Chairman 38
Legal and Regulatory 39
Oct 27, 2017: Redx Pharma: Update on Application to the High Court 39
Government and Public Interest 40
Mar 30, 2017: Redx Pharma awarded US$1 million grant by CARB-X 40
Product News 41
08/31/2017: Redx to present new scientific data at ESMO 2017 41
06/23/2017: Redx announces MHRA approval of its Clinical Trial Application for Porcupine Inhibitor RXC004 42
01/27/2017: Redx outlines growing opportunity for Porcupine inhibitors 43
01/22/2018: Redx Pharma Announces Appointment of Experienced Drug Development Clinician as Chief Medical Officer 44
Clinical Trials 45
Jan 22, 2018: Redx Pharma appoints chief medical officer who will oversee launch of phase I clinical trial of new cancer drug 45
Other Significant Developments 46
Nov 06, 2017: Redx Provides a Strategic Update and Announces that Trading is to recommence in its Shares 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Redx Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Redx Pharma Acquires ROCK Inhibitor AMA0825 from Amakem 11
Horizon Discovery Enters into Research Agreement with Redx Pharma 12
Astrazeneca Enters into Research Agreement with Redx Pharma 13
Redx Pharma Enters into Research Agreement with Pierre Fabre Labs 14
Deinove Enters into Option and Licensing Agreement with Redx Pharma 15
Redx Pharma Enters Into Licensing Agreement With Pharmascience For Cancer Program 16
Dotmatics Enters Into Licensing Agreement With Redx Pharma 17
Redx Pharma Enters Into Licensing Agreement With Dishman For Prescription Drug Technology 18
Redx Pharma to Raise USD15 Million in Private Placement of Shares 19
Redx Pharma to Raise USD3.6 Million in Rights Offering of Shares 21
Redx Pharma Raises USD14.2 Million in Private Placement of Shares 22
Redx Pharma Raises USD22.7 Million in IPO 23
Loxo Oncology Acquires BTK Inhibitor Program from Redx Pharma 24
Redx Pharma Plc, Key Competitors 25
Redx Pharma Plc, Key Employees 26
Redx Pharma Plc, Subsidiaries 27

List of Figures
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Redx Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9